|
Volumn 13, Issue 6, 1999, Pages 850-854
|
Treatment of newly diagnosed AML, RAEB-t or RAEB with lisofylline or placebo in addition to chemotherapy
a a a a a a a |
Author keywords
AML MDS; Infection; Lisofylline
|
Indexed keywords
ANTHRACYCLINE ANTIBIOTIC AGENT;
BILIRUBIN;
CREATININE;
CYTARABINE;
IDARUBICIN;
LISOFYLLINE;
PERIPHERAL VASODILATING AGENT;
PYRIMIDINE ANTAGONIST;
ACUTE GRANULOCYTIC LEUKEMIA;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DOUBLE BLIND PROCEDURE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG TOXICITY;
MAJOR CLINICAL STUDY;
MUCOSA INFLAMMATION;
NAUSEA;
NEUTROPHIL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REFRACTORY ANEMIA;
THROMBOCYTE COUNT;
VOMITING;
|
EID: 0033044845
PISSN: 08876924
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.leu.2401443 Document Type: Article |
Times cited : (6)
|
References (7)
|